XVIVO Presents Interim Report January-June 2022

GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Strong sales growth and increased gross marginsSecond quarter 2022 (Apr 1 - Jun 30)• Net sales amounted to SEK 94.3 million (59.3), corresponding to …